103 related articles for article (PubMed ID: 6427709)
1. Is filtration cost-effective in routine I.V. therapy?
Gill S
NITA; 1984; 7(3):227-9. PubMed ID: 6427709
[No Abstract] [Full Text] [Related]
2. Are i.v. in-line filters worth the price?
Gurevich I
Nursing; 1986 Jul; 16(7):42-3. PubMed ID: 3088501
[No Abstract] [Full Text] [Related]
3. [Infusion solutions: a controllable factor in hospital costs (author's transl)].
Artmann K; Göbel EA; Neumann H
MMW Munch Med Wochenschr; 1979 Jul; 121(27):921-2. PubMed ID: 112452
[TBL] [Abstract][Full Text] [Related]
4. The infusion projection.
Schaffer CL; Hughes CC
Contin Care; 1992 Apr; 11(3):12-4; 44. PubMed ID: 10148138
[No Abstract] [Full Text] [Related]
5. Care and cost-justification of final filtration.
Harrigan CA
NITA; 1985; 8(5):426-30. PubMed ID: 3850389
[No Abstract] [Full Text] [Related]
6. Automatic pipetters: applications and cost considerations in I.V. admixture programs.
Blackstone M; Hauser LD
Hosp Mater Manage Q; 1980 Feb; 1(3):69-85. PubMed ID: 10309094
[No Abstract] [Full Text] [Related]
7. Cost-effectiveness of standardized heparin and aminophylline solutions.
Jenkins J; Brown T
NITA; 1985; 8(2):162-4. PubMed ID: 3920579
[No Abstract] [Full Text] [Related]
8. A time and money saver? Cost comparison of i.v. therapy with and without Pall 96 filters.
Johnson S
Prof Nurse; 1994 Nov; 10(2):94-6. PubMed ID: 7800700
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness analysis as a tool to compare two methods of preparing and administering intravenous heparin solutions.
Oszko MA; Fant WK
Hosp Pharm; 1985 Aug; 20(8):576-8, 581-2. PubMed ID: 10311207
[TBL] [Abstract][Full Text] [Related]
10. Cost and time required to add potassium chloride to large-volume parenterals.
Turco SJ
Hosp Pharm; 1979 Dec; 14(12):718-9. PubMed ID: 10309084
[No Abstract] [Full Text] [Related]
11. The i.v. therapy team: impact on patient care and costs of hospitalization.
Tomford JW; Hershey CO
NITA; 1985; 8(5):387-9. PubMed ID: 3850385
[No Abstract] [Full Text] [Related]
12. [Hypodermoclysis, a neglected approach].
Mancini I; Body JJ
Rev Med Brux; 1998 Sep; 19(4):A327-31. PubMed ID: 9805967
[TBL] [Abstract][Full Text] [Related]
13. Cost-effective application of the Centers for Disease Control Guideline for Prevention of Intravascular Infections.
Frawley LW
Am J Infect Control; 1985 Dec; 13(6):275-7. PubMed ID: 3002213
[TBL] [Abstract][Full Text] [Related]
14. Dollars and sense looking at costs in patient care.
Sasmor JL
Am J Nurs; 1981 Mar; 81(3):546-7. PubMed ID: 6781345
[No Abstract] [Full Text] [Related]
15. Effect of inline filtration on postinfusion phlebitis.
Maddox RR; John JF; Brown LL; Smith CE
Clin Pharm; 1983; 2(1):58-61. PubMed ID: 6883931
[TBL] [Abstract][Full Text] [Related]
16. A comparison of premixed and non-premixed potassium chloride large-volume parenterals.
Turco SJ
Hosp Pharm; 1979 Dec; 14(12):720-2. PubMed ID: 10309085
[No Abstract] [Full Text] [Related]
17. Can i.v. filtration be cost-justified?
Rutherford C
NITA; 1985; 8(3):223-4. PubMed ID: 3846813
[No Abstract] [Full Text] [Related]
18. Unit-of-use versus traditional intravenous piggyback drug administration systems.
Tribble DA; Fotis M; McDonald DE
Am J Hosp Pharm; 1979 Jun; 36(6):739, 742. PubMed ID: 111545
[No Abstract] [Full Text] [Related]
19. Inline I.V. filters.
Jemison-Smith P; Belman B
Crit Care Update; 1981 Sep; 8(9):26-33. PubMed ID: 6912802
[No Abstract] [Full Text] [Related]
20. P&T Committee guidelines for antibiotic cost comparisons.
McCue JD
Hosp Formul; 1986 Jun; 21(6):703-6. PubMed ID: 10276798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
